Literature DB >> 16735250

Status of newborn screening programs in the United States.

Bradford L Therrell1, Alissa Johnson, Donna Williams.   

Abstract

BACKGROUND: Newborn screening programs have expanded over the years; currently, many programs screen for dozens of congenital conditions that, if not detected and treated early, could result in catastrophic health consequences, including death. Some programs, however, still require universal newborn screening for only a few conditions. Although all 51 US programs (all states and the District of Columbia) have statutory screening requirements and similarities exist in many parts of the different screening systems, the enabling statutes, rules, regulations, protocols, and financing strategies vary dramatically. Consequently, there is a significant lack of equity in newborn screening services across the country.
METHODS: We investigated program variations existing in and around January 2005 and provide baseline information with which future program comparisons can be made. We used program surveys, electronic searches of legislation, and individual input (validation) from program decision-makers to create a reservoir of program information.
RESULTS: Included is a compilation of pertinent newborn screening statutes, information from genetic privacy statutes that potentially affects newborn screening programs, and a review of state laws that affect specimen and information retention. In addition, program policies related to the use of residual newborn screening blood spots are reviewed, along with the developmental processes affecting program informational brochures, including the information contained and the strategies for brochure dissemination.
CONCLUSIONS: Building on a progressive and successful history, newborn screening continues as an example of an essential population genetic screening program. As the intricacies of screening systems have increased in complexity, so have the policy issues that shape program successes and failures. The summary information in this article provides a basis for national and individual program evaluation. Indeed, some of the information reported here has already been useful for program refinements reported elsewhere in this supplement.

Mesh:

Year:  2006        PMID: 16735250     DOI: 10.1542/peds.2005-2633C

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  31 in total

1.  Policy issues and stakeholder concerns regarding the storage and use of residual newborn dried blood samples for research.

Authors:  Erin Rothwell; Rebecca Anderson; Jeffrey Botkin
Journal:  Policy Polit Nurs Pract       Date:  2010-05-10

2.  Newborn screening education on the internet: a content analysis of North American newborn screening program websites.

Authors:  Makda H Araia; Beth K Potter
Journal:  J Community Genet       Date:  2011-04-15

3.  Newborn screening: from Guthrie to whole genome sequencing.

Authors:  Michele Caggana; Elizabeth A Jones; S I Shahied; Susan Tanksley; Cheryl A Hermerath; Ira M Lubin
Journal:  Public Health Rep       Date:  2013 Sep-Oct       Impact factor: 2.792

4.  Considering consent: a structural equation modelling analysis of factors influencing decisional quality when accepting newborn screening.

Authors:  Stuart G Nicholls; Kevin W Southern
Journal:  J Inherit Metab Dis       Date:  2013-09-17       Impact factor: 4.982

5.  Agency discretion and public health service delivery.

Authors:  Pamela J Clouser McCann
Journal:  Health Serv Res       Date:  2009-08-17       Impact factor: 3.402

6.  State laws regarding the retention and use of residual newborn screening blood samples.

Authors:  Michelle H Lewis; Aaron Goldenberg; Rebecca Anderson; Erin Rothwell; Jeffrey Botkin
Journal:  Pediatrics       Date:  2011-03-28       Impact factor: 7.124

7.  Storage and use of Newborn Screening Blood Specimens for Research: Assessing Public Opinion in Illinois.

Authors:  Alexa Hart; Michael Petros; Joel Charrow; Claudia Nash; Catherine Wicklund
Journal:  J Genet Couns       Date:  2014-11-20       Impact factor: 2.537

Review 8.  Newborn Screening for Lysosomal Storage Disorders.

Authors:  Roy W A Peake; Olaf A Bodamer
Journal:  J Pediatr Genet       Date:  2016-12-02

9.  Feasibility of neonatal dried blood spot retrieval amid evolving state policies (2009-2010): a Children's Oncology Group study.

Authors:  Amy M Linabery; Megan E Slater; Logan G Spector; Andrew F Olshan; Susan K Stork; Michelle A Roesler; Gregory H Reaman; Julie A Ross
Journal:  Paediatr Perinat Epidemiol       Date:  2011-08-10       Impact factor: 3.980

10.  Enamel defects and salivary methylmalonate in methylmalonic acidemia.

Authors:  C W Bassim; J T Wright; J P Guadagnini; R Muralidharan; J Sloan; D L Domingo; C P Venditti; T C Hart
Journal:  Oral Dis       Date:  2009-01-09       Impact factor: 3.511

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.